Boxmeer, Netherlands

Basav Hangalapura Nagaraj

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Intervet Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Basav Hangalapura Nagaraj. Retrieved from https://idiyas.com/inventor/basav-hangalapura-nagaraj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Basav Nagaraj

Introduction

Basav Nagaraj is a notable inventor based in Wageningen, Netherlands. He has made significant contributions to the field of vaccine development, particularly in combating swine influenza.

Latest Patents

Nagaraj holds a patent for a swine influenza A virus vaccine. This invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The patent also includes a vaccine against the influenza A virus comprising such vectors and/or nucleic acid constructs. Furthermore, it outlines methods of making and using the vaccines alone or in combination with other protective agents.

Career Highlights

Basav Nagaraj is currently employed at Intervet Inc., a company known for its focus on animal health and veterinary pharmaceuticals. His work in vaccine development has positioned him as a key figure in the fight against viral infections in swine.

Collaborations

Nagaraj has collaborated with notable colleagues, including Mark A Mogler and Pravina Kitikoon, to advance research and development in his field.

Conclusion

Basav Nagaraj's innovative work in vaccine technology exemplifies the importance of research in public health. His contributions are vital in the ongoing battle against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…